No Data
No Data
New Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market
Express News | Nexalin Technology Shares Resume Trade Following Circuit Breaker Halt
Nexalin Technology Releases Letter to Shareholders
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth?
Nexalin Technology's Strong Financial Position: No Defaults on Senior Securities
10-Q: Q3 2024 Earnings Report
No Data